Andrew Dodgson
Overview
Explore the profile of Andrew Dodgson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
120
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fowler T, Kenny C, Tunkel S, Dodgson A, Hall J, Marks P, et al.
J R Soc Med
. 2025 Feb;
:1410768251322225.
PMID: 40019173
No abstract available.
2.
Futschik M, Kulasegaran-Shylini R, Blandford E, Harper S, Chapman D, Turek E, et al.
BMC Glob Public Health
. 2025 Jan;
3(1):5.
PMID: 39806484
Background: The UK's National Health Service Test and Trace (NHSTT) program aimed to provide the most effective and accessible SARS-CoV-2 testing approach possible. Early user feedback indicated that there were...
3.
Fowler T, Blandford E, Chapman D, Futschik M, Kulasegaran-Shylini R, Tunkel S, et al.
Diagn Microbiol Infect Dis
. 2024 Oct;
111(1):116577.
PMID: 39481250
Purpose: The Omicron variant of SARS-CoV-2 raised concerns about the best sampling sites for PCR testing, with early indications suggesting throat swab samples were better than nasal swab samples. Our...
4.
Futschik M, Tunkel S, Turek E, Chapman D, Thorlu-Bangura Z, Kulasegaran-Shylini R, et al.
J Virol Methods
. 2024 Jul;
329:115000.
PMID: 39038659
Background/objectives: We investigated if performing two lateral flow device (LFD) tests, LFD2 immediately after LFD1, could improve diagnostic sensitivity or specificity for detecting severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2)...
5.
Fowler T, Chapman D, Futschik M, Tunkel S, Blandford E, Turek E, et al.
Eur J Clin Microbiol Infect Dis
. 2024 Jun;
43(8):1621-1630.
PMID: 38856828
Purpose: In April 2020, the UK Government implemented NHS Test and Trace to provide SARS-CoV-2 quantitative reverse transcription polymerase chain reaction (qRT-PCR) testing for the public, with nose-and-throat swabbing for...
6.
Ryan F, Cole-Hamilton J, Dandamudi N, Futschik M, Needham A, Saquib R, et al.
Sci Rep
. 2024 Mar;
14(1):7475.
PMID: 38553484
To detect SARS-CoV-2 amongst asymptomatic care home staff in England, a dual-technology weekly testing regime was introduced on 23 December 2020. A lateral flow device (LFD) and quantitative reverse transcription...
7.
Futschik M, Johnson S, Turek E, Chapman D, Carr S, Thorlu-Bangura Z, et al.
J Clin Virol
. 2024 Feb;
171:105654.
PMID: 38387136
Background: The advent of lateral flow devices (LFDs) for SARS-CoV-2 detection enabled widespread use of rapid self-tests during the pandemic. While self-testing using LFDs is now common, whether self-testing provides...
8.
Pople D, Kypraios T, Donker T, Stoesser N, Seale A, George R, et al.
BMC Med
. 2023 Dec;
21(1):492.
PMID: 38087343
Background: Globally, detections of carbapenemase-producing Enterobacterales (CPE) colonisations and infections are increasing. The spread of these highly resistant bacteria poses a serious threat to public health. However, understanding of CPE...
9.
OHara R, Brown B, Hughes A, McEwan A, Birtles A, Hawker A, et al.
J Clin Virol Plus
. 2022 Jul;
2(3):100098.
PMID: 35874465
Here we describe a retrospective clinical evaluation of the QIAGEN SARS-CoV-2 Prep&Amp UM RT-PCR assay that detects SARS-CoV-2 RNA without the need for a nucleic acid eluate extraction procedure. Using...
10.
Vlachaki I, Zinzi D, Falla E, Mantopoulos T, Guy H, Jandu J, et al.
Eur J Health Econ
. 2021 Sep;
23(3):537-549.
PMID: 34546484
Objective: The study objective of this analysis was to determine the cost-effectiveness of vaborem (meropenem-vaborbactam) compared to the best available therapy (BAT) in adult patients with carbapenem-resistant Enterobacteriaceae-Klebsiella pneumoniae carbapenemase...